Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study
Covid-19 및 Influenza A의 비타민 D 부전 및 중요한 질병 생존자 : 단면 연구
Infectious Diseases
[키워드] 25-hydroxy vitamin D
characterization
circulating
clinical
Concentration
correlated
COVID-19
COVID-19 pandemic
COVID-19 samples
Critical
Critical illness
cross-sectional
cross-sectional study
deficiency
determine
disrupt
ELISA
expected
Free
H1N1
Health
hospitalised
hospitalised patient
Hospitalised patients
hydroxy vitamin D
hypothese
hypotheses
Illness severity
immunology
immunomodulation
IMV
in-hospital mortality
Inflammatory mediators
Influenza
influenza A
insufficiency
intensive & critical care
Invasive mechanical ventilation
Liquid chromatography
majority
mass spectrometry
measure
mediators
metabolism
mosaic
objective
outcome measures
outcomes
pandemic
participant
Patient
people with COVID-19
persist
plasma
prevalent
progression
receipt
respiratory
respiratory infections
Result
selected
setting
severe disease
severity
steroid
steroid hormone
Support
survivor
Survivors
susceptibility
Tandem mass spectrometry
Total
Trial
Vitamin
Vitamin D
vitamin D deficiency
vitamin D insufficiency
was measured
was obtained
with COVID-19
[DOI] 10.1136/bmjopen-2021-055435 PMC 바로가기 [Article Type] Infectious Diseases
[DOI] 10.1136/bmjopen-2021-055435 PMC 바로가기 [Article Type] Infectious Diseases